NIAGEN BIOSCIENCE INCNAGE
ASignal's systematic analysis rates NAGE as Neutral.
Reflects the latest available analysis · analyzed Oct 12, 2026
The case on NAGE
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with debt-to-equity ratio of 0.03x
- High return on equity (21.80%) indicating efficient capital use
- Gross margin of 64.24% suggests strong pricing power
- Current ratio of 6.50x and quick ratio of 5.00x reflect exceptional liquidity
- RSI at 24.99 indicates deeply oversold conditions (potential reversal signal)
- Negative price momentum and declining MACD suggest ongoing downtrend
- Revenue and earnings declining YoY by 4.3% and 75% respectively
- Forward P/E of 26.30x appears elevated relative to negative growth
- Low news coverage with only 2 sources and no Reddit mentions
- Price trading below both SMA20 and SMA50, indicating bearish trend
See the full verdict on NAGE
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NAGE
Most investors never get a second opinion, let alone several. ASignal runs NAGE past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.